eClinical Tech News

Genfit will use AASLD The Liver Meeting 2025 to showcase breadth across its hepatology portfolio, led by new preclinical...

Journey Medical’s FDA-approved Emrosi (DFD-29, 40 mg minocycline hydrochloride modified-release) is now available in the United States for adults...

Health Canada has granted a Notice of Compliance with Conditions for Leqembi (lecanemab) for adults with mild cognitive impairment...

Novartis has agreed to acquire Avidity Biosciences for $12 billion in cash, consolidating control of a late-stage pipeline built...

Sobi North America is spotlighting 15 presentations at ACR Convergence 2025, featuring new Phase 3 analyses for its investigational...

Enzon Pharmaceuticals and Viskase Companies have amended their previously announced all-stock merger, resetting ownership so Viskase holders will own...

Inotiv will hit the investor circuit in November, with management slated for one-on-one meetings at the UBS Global Healthcare...

Nurexone Biologic will take the regulatory stage at the Precision EV Forum 2025 in Cambridge, UK, where its Director...

Rhythm Pharmaceuticals will report third-quarter 2025 results on November 4 and is lining up two investor discussions on November...

Cytomed Therapeutics has submitted a cash bid to acquire selected assets of TC BioPharm, which entered administration on October...